Norges Bank Tg Therapeutics, Inc. Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$13.32 - $19.19 $7.96 Million - $11.5 Million
597,300 New
597,300 $10.6 Million
Q4 2023

Feb 09, 2024
BUY
$6.68 - $18.81 $7.18 Million - $20.2 Million
1,075,037 New
1,075,037 $18.4 Million
Q3 2023

Nov 13, 2024
BUY
$8.36 - $26.5 $7.71 Million - $24.4 Million
922,112 New
922,112 $7.71 Million
Q3 2023

Nov 13, 2023
SELL
$8.36 - $26.5 $9.49 Million - $30.1 Million
-1,135,092 Closed
0 $0
Q2 2023

Aug 14, 2024
BUY
$15.48 - $35.0 $5.03 Million - $11.4 Million
324,812 Added 54.38%
922,112 $22.9 Million
Q2 2023

Aug 14, 2023
SELL
$15.48 - $35.0 $16.5 Million - $37.3 Million
-1,066,599 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$10.23 - $19.34 $9.65 Million - $18.2 Million
943,169 New
943,169 $14.2 Million
Q4 2022

Feb 14, 2023
BUY
$5.01 - $11.83 $5.69 Million - $13.4 Million
1,135,092 New
1,135,092 $13.4 Million
Q3 2022

Nov 13, 2023
BUY
$4.57 - $8.4 $5.19 Million - $9.53 Million
1,135,092 New
1,135,092 $6.72 Million
Q2 2022

Aug 14, 2023
BUY
$3.74 - $10.66 $3.99 Million - $11.4 Million
1,066,599 New
1,066,599 $4.53 Million
Q1 2022

May 12, 2023
SELL
$7.81 - $20.45 $934,622 - $2.45 Million
-119,670 Reduced 10.54%
1,015,422 $9.66 Million
Q1 2022

May 09, 2022
SELL
$7.81 - $20.45 $7.99 Million - $20.9 Million
-1,022,922 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$15.2 - $35.51 $15.5 Million - $36.3 Million
1,022,922 New
1,022,922 $19.4 Million
Q3 2021

Nov 14, 2022
BUY
$21.78 - $40.45 $18 Million - $33.4 Million
824,824 New
824,824 $27.5 Million
Q3 2021

Nov 05, 2021
SELL
$21.78 - $40.45 $24.4 Million - $45.3 Million
-1,118,783 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$32.5 - $48.96 $36.4 Million - $54.8 Million
1,118,783 New
1,118,783 $43.4 Million
Q2 2021

Aug 10, 2021
SELL
$32.5 - $48.96 $34.8 Million - $52.5 Million
-1,071,846 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$41.61 - $54.3 $44.6 Million - $58.2 Million
1,071,846 New
1,071,846 $51.7 Million
Q1 2021

May 07, 2021
SELL
$41.61 - $54.3 $53.1 Million - $69.3 Million
-1,275,493 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$25.27 - $54.9 $32.2 Million - $70 Million
1,275,493 New
1,275,493 $66.4 Million
Q4 2020

Feb 10, 2021
SELL
$25.27 - $54.9 $31.9 Million - $69.2 Million
-1,260,410 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$18.49 - $27.24 $23.3 Million - $34.3 Million
1,260,410 New
1,260,410 $33.7 Million
Q3 2020

Nov 10, 2020
SELL
$18.49 - $27.24 $369,799 - $544,800
-20,000 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$8.9 - $21.84 $178,000 - $436,800
20,000 New
20,000 $390,000
Q2 2019

Aug 09, 2019
SELL
$6.27 - $8.65 $627,000 - $865,000
-100,000 Closed
0 $0
Q1 2019

May 11, 2020
BUY
$4.02 - $8.04 $401,999 - $803,999
100,000 New
100,000 $804,000

Others Institutions Holding TGTX

# of Institutions
336
Shares Held
87.6M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.23B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email